Marinus Pharmaceuticals logo
Marinus Pharmaceuticals MRNS

Quarterly report 2024-Q3
added 05-16-2026

report update icon

Marinus Pharmaceuticals Cash Conversion Cycle 2011-2026 | MRNS

Annual Cash Conversion Cycle Marinus Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
59.8 64.3 -608 175 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
175 -608 -77.3

Quarterly Cash Conversion Cycle Marinus Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
38.9 39.4 43.4 - 59.2 127 79.3 - 125 -171 -288 - -112 - 41.6 - 439 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
439 -288 35.1

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
3.11 K - 5743.5 % $ 69.7 M canadaCanada
Coherus BioSciences Coherus BioSciences
CHRS
149 $ 1.57 -3.68 % $ 184 M usaUSA
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
-3.12 K - 1.35 % $ 17.8 M chinaChina
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
205 $ 16.87 -2.49 % $ 789 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
-1.97 K - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
-58 - - $ 96.9 B britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
17 - -1.52 % $ 24.7 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
21.2 $ 7.47 -4.6 % $ 205 M israelIsrael
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
115 $ 30.26 1.0 % $ 814 M usaUSA
Exelixis Exelixis
EXEL
-8.32 $ 50.13 -1.9 % $ 13.6 B usaUSA
Fortress Biotech Fortress Biotech
FBIO
-74.9 $ 2.41 4.78 % $ 67.2 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
82.8 - -18.52 % $ 27.3 M britainBritain
AbCellera Biologics AbCellera Biologics
ABCL
173 $ 4.09 -7.05 % $ 1.22 B canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
119 $ 1.63 2.52 % $ 434 M britainBritain
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Celyad Oncology SA Celyad Oncology SA
CYAD
-55.7 K - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
214 - -7.31 % $ 87 M usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
47.6 - - $ 344 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-2.15 K - - $ 7.46 M israelIsrael
Gilead Sciences Gilead Sciences
GILD
115 $ 129.58 -1.88 % $ 161 B usaUSA
Advaxis Advaxis
ADXS
-82.3 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-34.3 K - 5.93 % $ 314 M canadaCanada
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
126 - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
-1.92 - 1.93 % $ 17.4 M usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
-193 $ 0.72 -1.58 % $ 32.9 M israelIsrael
Esperion Therapeutics Esperion Therapeutics
ESPR
99.7 $ 3.12 - $ 649 M usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
-1.55 K - -0.23 % $ 916 M usaUSA